Last reviewed · How we verify

NCT07108959: ESPB

ESPB Versus Perioperative Iv Lidocaine Infusion on Proinflammatory Cytokines in Breast Cancer Surgeries

Not yet recruiting NA Last updated 7 August 2025
What this trial tests

NA trial testing Erector spinae plane block (Group E) in Breast Cancer in 40 participants. Not yet recruiting.

Timeline
1 August 2025
Primary endpoint
31 December 2026
31 December 2026

Quick facts

Lead sponsorAlexandria University
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeprevention
Enrollment40
Start date1 August 2025
Primary completion31 December 2026
Estimated completion31 December 2026
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Alexandria University

Who can join

Adults 30 to 60, female only, with Breast Cancer or ESPB. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The present study aims to compare the effect of ESPB versus perioperative iv lidocaine infusion on proinflammatory cytokines in breast cancer surgeries.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Erector spinae plane block (Group E)

Trials testing the same drug.

Other recruiting trials for Breast Cancer

Currently open trials in the same condition.

Other Alexandria University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07108959.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing